L.M. Shlapatska - Concepedia

Author

L.M. Shlapatska

R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology ORCID

Also Known As

L M Shlapatska, L Shlapatska, L. M. Shlapatska, L. SHLAPATSKA, L. Shlapatska, L.M. Shlapatska, Larisa M Shlapatska, Larysa M Shlapatska, Larysa M. Shlapatska, Larysa Shlapatska

Publications

611

Citations

H-Index

Concepts

All Affiliations

R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology University of Washington Children's Hospital of Philadelphia National Academy of Sciences of Ukraine

About

L.M. Shlapatska is an author at R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology specializing in immunology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	183
2	Cell Biology	5	5	183
3	Immunology	5	5	183
4	Pathology	2	2	41
5	Autoimmunity	2	2	47

L.M. Shlapatska

Publications

543

Citations

H-Index

Page 1

	Year	Citations
CD150 Association with Either the SH2-Containing Inositol Phosphatase or the SH2-Containing Protein Tyrosine Phosphatase Is Regulated by the Adaptor Protein SH2D1A L.M. Shlapatska, Anna G. Berdova, Oleksander M. Zelensky, The Journal of Immunology	2001	214
CDw150 Associates with Src-Homology 2-Containing Inositol Phosphatase and Modulates CD95-Mediated Apoptosis L.M. Shlapatska, Anna G. Berdova, Che‐Leung Law, The Journal of Immunology Cdw150 LigationApoptosisImmunologyCell DeathB Cell Proliferation	1999	98
The adaptor protein SH2D1A regulates signaling through CD150 (SLAM) in B cells L.M. Shlapatska, Olga V. Yurchenko, Maria Yurchenko, Blood	2004	51
CD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cells Maria Yurchenko, Larysa Kovalevska, L.M. Shlapatska, Immunology and Cell Biology Lymphoid NeoplasiaJnk ActivityReceptor Tyrosine KinaseImmunologyJnk1/2 Activation	2010	25
Differential expression of PKD1 and PKD2 in gastric cancer and analysis of PKD1 and PKD2 function in the model system. M Yu Shabelnik, Larysa Kovalevska, Maria Yurchenko, PubMed	2011	23
The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling Inna Gordiienko, L.M. Shlapatska, Valeriia Kholodniuk, PLoS ONE Mixed-phenotype Acute LeukemiaImmunologyImmune RegulationImmunologic MechanismMtor Dependent Pathways	2017	22
The multilevel regulation of CD95 signaling outcome. Maria Yurchenko, L.M. Shlapatska, Sidorenko Sp PubMed ApoptosisImmunologyImmune RegulationCell DeathMultilevel Control	2012	22
Immunohistochemical studies of protein kinase D (PKD) 2 expression in malignant human lymphomas. Larysa Kovalevska, Yurchenko Ov, L.M. Shlapatska, PubMed	2006	19
DIFFERENTIAL EXPRESSION OF CD150/SLAMF1 IN NORMAL AND MALIGNANT B CELLS ON THE DIFFERENT STAGES OF MATURATION L.M. Shlapatska, Larysa Kovalevska, Sidorenko Sp Experimental Oncology	2016	17
Expression of CD150 in Tumors of the Central Nervous System: Identification of a Novel Isoform Olga Romanets-Korbut, Alexander M. Najakshin, Maria Yurchenko, PLoS ONE Neuro-oncologyTumor InnervationGliomaMalignant DiseaseImmunology	2015	16

Page 1